These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31700973)

  • 41. Skin and metabolic syndrome: A review of the possible associations.
    Adibi N; Robati RM
    J Res Med Sci; 2021; 26():16. PubMed ID: 34084195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testosterone and metabolic syndrome.
    Cunningham GR
    Asian J Androl; 2015; 17(2):192-6. PubMed ID: 25652634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype.
    Engmann L; Jin S; Sun F; Legro RS; Polotsky AJ; Hansen KR; Coutifaris C; Diamond MP; Eisenberg E; Zhang H; Santoro N;
    Am J Obstet Gynecol; 2017 May; 216(5):493.e1-493.e13. PubMed ID: 28104402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endocrinologic Aspects of Hidradenitis Suppurativa.
    Karagiannidis I; Nikolakis G; Zouboulis CC
    Dermatol Clin; 2016 Jan; 34(1):45-9. PubMed ID: 26617357
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
    Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
    Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M
    Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polycystic ovary syndrome in men: Stein-Leventhal syndrome revisited.
    Kurzrock R; Cohen PR
    Med Hypotheses; 2007; 68(3):480-3. PubMed ID: 17134841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acne as a chronic systemic disease.
    Zouboulis CC
    Clin Dermatol; 2014; 32(3):389-96. PubMed ID: 24767186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of sex steroids on women's health: implications for practitioners.
    Derman RJ
    Am J Med; 1995 Jan; 98(1A):137S-143S. PubMed ID: 7825634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dermatology of androgen-related disorders.
    Essah PA; Wickham EP; Nunley JR; Nestler JE
    Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cross-sectional association between testosterone, sex hormone-binding globulin and metabolic syndrome: The Healthy Twin Study.
    Moon H; Choi I; Kim S; Ko H; Shin J; Lee K; Sung J; Song YM
    Clin Endocrinol (Oxf); 2017 Nov; 87(5):523-531. PubMed ID: 28581026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of insulin resistance with hyperandrogenia in women.
    Pugeat M; Ducluzeau PH; Mallion-Donadieu M
    Horm Res; 2000; 54(5-6):322-6. PubMed ID: 11595827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women.
    Boyle JA; Cunningham J; Norman RJ; Dunbar T; O'Dea K
    Intern Med J; 2015 Dec; 45(12):1247-54. PubMed ID: 26387977
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of Perforin and Granzyme-B Levels with Hyperandrogenism in Polycystic Ovary Syndrome: A Case-Control Study.
    Zarei E; Mohajery H; Aliakbari F; Zadeh FM; Veghari G; Mansourian A
    Pak J Biol Sci; 2019 Jan; 22(8):393-399. PubMed ID: 31930827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation of Skin Changes with Hormonal Changes in Polycystic Ovarian Syndrome: A Cross-sectional Study Clinical Study.
    Gowri BV; Chandravathi PL; Sindhu PS; Naidu KS
    Indian J Dermatol; 2015; 60(4):419. PubMed ID: 26288423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans associated with polycystic ovary syndrome: clinical and laboratory features.
    Taketani Y; Mizuno M
    Horm Res; 1990; 33 Suppl 2():27-30. PubMed ID: 2095357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Woman 19-old with hirsutism, obesity and acanthosis nigricans].
    Kępczyńska-Nyk A; Muszel M; Radziszewski M; Wocial K
    Pol Merkur Lekarski; 2016 Sep; 41(243):141-144. PubMed ID: 27755516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic syndrome and inflammatory skin conditions.
    Steele CE; Morrell D; Evans M
    Curr Opin Pediatr; 2019 Aug; 31(4):515-522. PubMed ID: 31169544
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormonal and metabolic aspects of acne vulgaris in women with polycystic ovary syndrome.
    Franik G; Bizoń A; Włoch S; Kowalczyk K; Biernacka-Bartnik A; Madej P
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4411-4418. PubMed ID: 30058676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic syndrome in patients with the polycystic ovary syndrome.
    Panidis D; Tziomalos K; Papadakis E
    Expert Rev Endocrinol Metab; 2013 Nov; 8(6):559-568. PubMed ID: 30736140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.